1. Home
  2. GEO vs NVAX Comparison

GEO vs NVAX Comparison

Compare GEO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geo Group Inc (The) REIT

GEO

Geo Group Inc (The) REIT

N/A

Current Price

$16.99

Market Cap

2.0B

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$9.33

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEO
NVAX
Founded
1984
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
GEO
NVAX
Price
$16.99
$9.33
Analyst Decision
Strong Buy
Hold
Analyst Count
3
9
Target Price
$39.67
$11.33
AVG Volume (30 Days)
2.5M
4.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
727.27
309.76
EPS
1.82
2.58
Revenue
$2,263,420,000.00
$1,123,479,000.00
Revenue This Year
$13.74
N/A
Revenue Next Year
$9.99
N/A
P/E Ratio
$9.31
$3.62
Revenue Growth
3.85
64.69
52 Week Low
$12.51
$5.01
52 Week High
$32.09
$11.85

Technical Indicators

Market Signals
Indicator
GEO
NVAX
Relative Strength Index (RSI) 64.44 45.71
Support Level $16.01 $9.14
Resistance Level $17.64 $10.42
Average True Range (ATR) 0.73 0.55
MACD 0.33 -0.16
Stochastic Oscillator 91.53 3.97

Price Performance

Historical Comparison
GEO
NVAX

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: